Current best practices and rationalistic perspectives in causation-based prevention, early detection and multidisciplinary treatment of breast and gastric cancer

PAST ISSUES
Volume 11
Number 3

Novel breast cancer subtypes with integrative genomic and transcriptome analysis.
108-110
Cancer single pathways inhibitors: More resistance than durable success in the clinic
111-117
Resistance to everolimus treatment of renal cancer, intratumor heterogeneity and new therapeutic approaches.
118-120
Tumor diversity: Implementing NGS into clinic
121-126
100 breast cancer genome sequencing: Heterogeneity-based diagnostic and therapeutic perspectives.
127-130
Overcoming resistance to cetuximab or panitumumab in KRAS wild-type colorectal cancer.
131-134
Triple-negative breast cancer: From microarrays basal-like subtype to NGS molecular classification and new drugs development.
135-139
Robots and surgeons: Do patients benefit?
140-142
Neoadjuvant treatment and laparoscopic rectal cancer: Precision genomic medicine essential for improving patient's outcomes.
143-145
Gastric cancer perspectives: Laparoscopic surgery and systems approach polypharmacology.
146-148
Breast cancer advances in clinical cancer genome era: from conventional to integrative genome analysis.
149-150
Vemurafenib plus cetuximab or gefitinib for BRAF(V600E) mutant colorectal cancer.
151-153
Preoperative chemoradiotherapy for rectal cancer: Why revision and concerns are now shaped?
154-156
10.2122/gbc.2012.0238
Total mesorectal excision for rectal cancer: Laparoscopic or robotic approach?
157-159
10.2122/gbc.2012.0239
Dual inhibition of HER2 for a safe increase of efficacy in breast cancer.
160-162
10.2122/gbc.2012.0240
Everolimus added to aromatase inhibitors for improving hormone-receptor-positive breast cancer outcomes.
163-165
10.2122/gbc.2012.0241
Predictive molecular tools to personalized gastric cancer  targeted therapy.
166-179
10.2122/gbc.2012.0225
The emerging role of miRNAs in translational cancer medicine.
180-195
10.2122/gbc.2012.0227

Online ISSN : 1109 - 7647
Print ISSN : 1109 - 7655

We subscribe to the HONcode principles of the HON Foundation. Click to verify. We subscribe to the HONcode principles. Verify here.
please, read our policy about privacy and confidentiality of information and transparency of sponsorship

last update: 21 December 2012